Table I.

Correlation between miR-30d expression and clinicopathologic parameters in the patients with CRC.

Parameters	No. of cases	miR-30d expression		P-value	LRH-1 expression		P-value
		High (37)	Low (43)		Low (29)	High (51)
Age (years)				0.071			0.169
>60	44	16	28		19	25
≤60	36	21	15		10	26
Gender				0.262			0.486
Male	41	16	25		13	28
Female	39	21	18		16	23
Distant metastasis				<0.05a			<0.05a
M0	46	30	16		25	21
M1	34	14	20		10	24
TNM stage				<0.01b			<0.05a
I–II	34	22	12		7	27
III–IV	46	15	31		22	24
Degree of differentiation				<0.05a			0.345
Well/moderate	27	17	10		14	13
Poor	53	20	33		21	32
Invasive depth				<0.05a			<0.05a
T1-T2	32	20	12		17	15
T3-T4	48	17	31		12	36
Lymph node metastasis				<0.01b			<0.05a
Yes	36	25	11		18	18
No	44	12	32		11	33
Tumor size (cm)				0.262			0.647
>5	41	19	22		16	25
≤5	39	13	26		13	26

^aStatistically significant difference;

^bhighly significant difference. CRC, colorectal cancer; LRH-1, liver receptor homologue-1.